Safety Information & Precautions Before using Wegovy, inform your healthcare provider if you have: History of thyroid cancer Multiple endocrine neoplasia syndrome type 2 Pancreatitis history Gallbladder disease Kidney disease Severe gastrointestinal disorders Important safety considerations include: Use only under medical supervision Follow the prescribed dosing schedule Do not exceed recommended dosage Monitor for unusual symptoms Higher-dose semaglutide therapy such as Wegovy FlexTouch Pen 1.7 Mg may be used within advanced weight-management treatment plans
Pay over 3 EQUAL zero-interest instalments of R517.34 with PayJustNow
Hypoglycaemia risk is increased when Mounjaro is used in combination with insulin or sulfonylureas
It represents a next-generation incretin-based compound of significant interest in metabolic disease research, with studied effects on energy homeostasis, insulin secretion, and lipid metabolism in preclinical models
Our products are manufactured in compliance with all the necessary guidelines in certified facilities with 100 percent authentic and pure raw ingredients
This appetite suppression contributes to weight loss, which varies by dose and individual factorsclinical trials have shown weight reductions typically ranging from 5-15% in people with type 2 diabetes and higher (up to 20% at maximum doses) in people without diabetes over 72 weeks
.webp)
